Global Tuberculosis Testing and Diagnostics Market 2022 by Company, Regions, Type and Application, Forecast to 2028
Page: 113
Published Date: 11 Jan 2022
Category: Medical Care
PDF Download
Get FREE Sample
Customize Request
-
Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Description
The Tuberculosis Testing and Diagnostics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Tuberculosis Testing and Diagnostics market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Hospitals and Clinics accounting for % of the Tuberculosis Testing and Diagnostics global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Smear Microscopy segment is altered to a % CAGR between 2022 and 2028.
Global key companies of Tuberculosis Testing and Diagnostics include Roche, Thermo Fischer Scientific, Becton Dickinson, Abbott, and Hologic, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Tuberculosis Testing and Diagnostics market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Smear Microscopy
Nucleic Acid Testing
Radiography
Tuberculin Skin Test (TST)
Interferon Gamma Released Assay (IGRA)
Others
Market segment by Application, can be divided into
Hospitals and Clinics
Diagnostic Laboratories
Others
Market segment by players, this report covers
Roche
Thermo Fischer Scientific
Becton Dickinson
Abbott
Hologic
Qiagen
Sanofi
Oxford Immunotec
BioMerieux
Par Sterile
Bio-Rad Laboratories
Akonni Biosystems
Cepheid
Siemens Healthineer
Hain Lifescience
Epistem
Creative Diagnostics
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Tuberculosis Testing and Diagnostics product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Tuberculosis Testing and Diagnostics, with revenue, gross margin and global market share of Tuberculosis Testing and Diagnostics from 2019 to 2022.
Chapter 3, the Tuberculosis Testing and Diagnostics competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Tuberculosis Testing and Diagnostics market forecast, by regions, type and application, with revenue, from 2023 to 2028.
Chapter 11 and 12, to describe Tuberculosis Testing and Diagnostics research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Product Overview and Scope of Tuberculosis Testing and Diagnostics
1.2 Classification of Tuberculosis Testing and Diagnostics by Type
1.2.1 Overview: Global Tuberculosis Testing and Diagnostics Market Size by Type: 2017 Versus 2021 Versus 2028
1.2.2 Global Tuberculosis Testing and Diagnostics Revenue Market Share by Type in 2021
1.2.3 Smear Microscopy
1.2.4 Nucleic Acid Testing
1.2.5 Radiography
1.2.6 Tuberculin Skin Test (TST)
1.2.7 Interferon Gamma Released Assay (IGRA)
1.2.8 Others
1.3 Global Tuberculosis Testing and Diagnostics Market by Application
1.3.1 Overview: Global Tuberculosis Testing and Diagnostics Market Size by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospitals and Clinics
1.3.3 Diagnostic Laboratories
1.3.4 Others
1.4 Global Tuberculosis Testing and Diagnostics Market Size & Forecast
1.5 Global Tuberculosis Testing and Diagnostics Market Size and Forecast by Region
1.5.1 Global Tuberculosis Testing and Diagnostics Market Size by Region: 2017 VS 2021 VS 2028
1.5.2 Global Tuberculosis Testing and Diagnostics Market Size by Region, (2017-2022)
1.5.3 North America Tuberculosis Testing and Diagnostics Market Size and Prospect (2017-2028)
1.5.4 Europe Tuberculosis Testing and Diagnostics Market Size and Prospect (2017-2028)
1.5.5 Asia-Pacific Tuberculosis Testing and Diagnostics Market Size and Prospect (2017-2028)
1.5.6 South America Tuberculosis Testing and Diagnostics Market Size and Prospect (2017-2028)
1.5.7 Middle East and Africa Tuberculosis Testing and Diagnostics Market Size and Prospect (2017-2028)
1.6 Market Drivers, Restraints and Trends
1.6.1 Tuberculosis Testing and Diagnostics Market Drivers
1.6.2 Tuberculosis Testing and Diagnostics Market Restraints
1.6.3 Tuberculosis Testing and Diagnostics Trends Analysis
2.1 Roche
2.1.1 Roche Details
2.1.2 Roche Major Business
2.1.3 Roche Tuberculosis Testing and Diagnostics Product and Solutions
2.1.4 Roche Tuberculosis Testing and Diagnostics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.1.5 Roche Recent Developments and Future Plans
2.2 Thermo Fischer Scientific
2.2.1 Thermo Fischer Scientific Details
2.2.2 Thermo Fischer Scientific Major Business
2.2.3 Thermo Fischer Scientific Tuberculosis Testing and Diagnostics Product and Solutions
2.2.4 Thermo Fischer Scientific Tuberculosis Testing and Diagnostics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2.5 Thermo Fischer Scientific Recent Developments and Future Plans
2.3 Becton Dickinson
2.3.1 Becton Dickinson Details
2.3.2 Becton Dickinson Major Business
2.3.3 Becton Dickinson Tuberculosis Testing and Diagnostics Product and Solutions
2.3.4 Becton Dickinson Tuberculosis Testing and Diagnostics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3.5 Becton Dickinson Recent Developments and Future Plans
2.4 Abbott
2.4.1 Abbott Details
2.4.2 Abbott Major Business
2.4.3 Abbott Tuberculosis Testing and Diagnostics Product and Solutions
2.4.4 Abbott Tuberculosis Testing and Diagnostics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4.5 Abbott Recent Developments and Future Plans
2.5 Hologic
2.5.1 Hologic Details
2.5.2 Hologic Major Business
2.5.3 Hologic Tuberculosis Testing and Diagnostics Product and Solutions
2.5.4 Hologic Tuberculosis Testing and Diagnostics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5.5 Hologic Recent Developments and Future Plans
2.6 Qiagen
2.6.1 Qiagen Details
2.6.2 Qiagen Major Business
2.6.3 Qiagen Tuberculosis Testing and Diagnostics Product and Solutions
2.6.4 Qiagen Tuberculosis Testing and Diagnostics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6.5 Qiagen Recent Developments and Future Plans
2.7 Sanofi
2.7.1 Sanofi Details
2.7.2 Sanofi Major Business
2.7.3 Sanofi Tuberculosis Testing and Diagnostics Product and Solutions
2.7.4 Sanofi Tuberculosis Testing and Diagnostics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7.5 Sanofi Recent Developments and Future Plans
2.8 Oxford Immunotec
2.8.1 Oxford Immunotec Details
2.8.2 Oxford Immunotec Major Business
2.8.3 Oxford Immunotec Tuberculosis Testing and Diagnostics Product and Solutions
2.8.4 Oxford Immunotec Tuberculosis Testing and Diagnostics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8.5 Oxford Immunotec Recent Developments and Future Plans
2.9 BioMerieux
2.9.1 BioMerieux Details
2.9.2 BioMerieux Major Business
2.9.3 BioMerieux Tuberculosis Testing and Diagnostics Product and Solutions
2.9.4 BioMerieux Tuberculosis Testing and Diagnostics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9.5 BioMerieux Recent Developments and Future Plans
2.10 Par Sterile
2.10.1 Par Sterile Details
2.10.2 Par Sterile Major Business
2.10.3 Par Sterile Tuberculosis Testing and Diagnostics Product and Solutions
2.10.4 Par Sterile Tuberculosis Testing and Diagnostics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10.5 Par Sterile Recent Developments and Future Plans
2.11 Bio-Rad Laboratories
2.11.1 Bio-Rad Laboratories Details
2.11.2 Bio-Rad Laboratories Major Business
2.11.3 Bio-Rad Laboratories Tuberculosis Testing and Diagnostics Product and Solutions
2.11.4 Bio-Rad Laboratories Tuberculosis Testing and Diagnostics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11.5 Bio-Rad Laboratories Recent Developments and Future Plans
2.12 Akonni Biosystems
2.12.1 Akonni Biosystems Details
2.12.2 Akonni Biosystems Major Business
2.12.3 Akonni Biosystems Tuberculosis Testing and Diagnostics Product and Solutions
2.12.4 Akonni Biosystems Tuberculosis Testing and Diagnostics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12.5 Akonni Biosystems Recent Developments and Future Plans
2.13 Cepheid
2.13.1 Cepheid Details
2.13.2 Cepheid Major Business
2.13.3 Cepheid Tuberculosis Testing and Diagnostics Product and Solutions
2.13.4 Cepheid Tuberculosis Testing and Diagnostics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13.5 Cepheid Recent Developments and Future Plans
2.14 Siemens Healthineer
2.14.1 Siemens Healthineer Details
2.14.2 Siemens Healthineer Major Business
2.14.3 Siemens Healthineer Tuberculosis Testing and Diagnostics Product and Solutions
2.14.4 Siemens Healthineer Tuberculosis Testing and Diagnostics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.14.5 Siemens Healthineer Recent Developments and Future Plans
2.15 Hain Lifescience
2.15.1 Hain Lifescience Details
2.15.2 Hain Lifescience Major Business
2.15.3 Hain Lifescience Tuberculosis Testing and Diagnostics Product and Solutions
2.15.4 Hain Lifescience Tuberculosis Testing and Diagnostics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.15.5 Hain Lifescience Recent Developments and Future Plans
2.16 Epistem
2.16.1 Epistem Details
2.16.2 Epistem Major Business
2.16.3 Epistem Tuberculosis Testing and Diagnostics Product and Solutions
2.16.4 Epistem Tuberculosis Testing and Diagnostics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.16.5 Epistem Recent Developments and Future Plans
2.17 Creative Diagnostics
2.17.1 Creative Diagnostics Details
2.17.2 Creative Diagnostics Major Business
2.17.3 Creative Diagnostics Tuberculosis Testing and Diagnostics Product and Solutions
2.17.4 Creative Diagnostics Tuberculosis Testing and Diagnostics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.17.5 Creative Diagnostics Recent Developments and Future Plans
3.1 Global Tuberculosis Testing and Diagnostics Revenue and Share by Players (2019, 2020, 2021, and 2022)
3.2 Market Concentration Rate
3.2.1 Top 3 Tuberculosis Testing and Diagnostics Players Market Share in 2021
3.2.2 Top 10 Tuberculosis Testing and Diagnostics Players Market Share in 2021
3.2.3 Market Competition Trend
3.3 Tuberculosis Testing and Diagnostics Players Head Office, Products and Services Provided
3.4 Tuberculosis Testing and Diagnostics Mergers & Acquisitions
3.5 Tuberculosis Testing and Diagnostics New Entrants and Expansion Plans
4.1 Global Tuberculosis Testing and Diagnostics Revenue and Market Share by Type (2017-2022)
4.2 Global Tuberculosis Testing and Diagnostics Market Forecast by Type (2023-2028)
5.1 Global Tuberculosis Testing and Diagnostics Revenue Market Share by Application (2017-2022)
5.2 Global Tuberculosis Testing and Diagnostics Market Forecast by Application (2023-2028)
6.1 North America Tuberculosis Testing and Diagnostics Revenue by Type (2017-2028)
6.2 North America Tuberculosis Testing and Diagnostics Revenue by Application (2017-2028)
6.3 North America Tuberculosis Testing and Diagnostics Market Size by Country
6.3.1 North America Tuberculosis Testing and Diagnostics Revenue by Country (2017-2028)
6.3.2 United States Tuberculosis Testing and Diagnostics Market Size and Forecast (2017-2028)
6.3.3 Canada Tuberculosis Testing and Diagnostics Market Size and Forecast (2017-2028)
6.3.4 Mexico Tuberculosis Testing and Diagnostics Market Size and Forecast (2017-2028)
7.1 Europe Tuberculosis Testing and Diagnostics Revenue by Type (2017-2028)
7.2 Europe Tuberculosis Testing and Diagnostics Revenue by Application (2017-2028)
7.3 Europe Tuberculosis Testing and Diagnostics Market Size by Country
7.3.1 Europe Tuberculosis Testing and Diagnostics Revenue by Country (2017-2028)
7.3.2 Germany Tuberculosis Testing and Diagnostics Market Size and Forecast (2017-2028)
7.3.3 France Tuberculosis Testing and Diagnostics Market Size and Forecast (2017-2028)
7.3.4 United Kingdom Tuberculosis Testing and Diagnostics Market Size and Forecast (2017-2028)
7.3.5 Russia Tuberculosis Testing and Diagnostics Market Size and Forecast (2017-2028)
7.3.6 Italy Tuberculosis Testing and Diagnostics Market Size and Forecast (2017-2028)
8.1 Asia-Pacific Tuberculosis Testing and Diagnostics Revenue by Type (2017-2028)
8.2 Asia-Pacific Tuberculosis Testing and Diagnostics Revenue by Application (2017-2028)
8.3 Asia-Pacific Tuberculosis Testing and Diagnostics Market Size by Region
8.3.1 Asia-Pacific Tuberculosis Testing and Diagnostics Revenue by Region (2017-2028)
8.3.2 China Tuberculosis Testing and Diagnostics Market Size and Forecast (2017-2028)
8.3.3 Japan Tuberculosis Testing and Diagnostics Market Size and Forecast (2017-2028)
8.3.4 South Korea Tuberculosis Testing and Diagnostics Market Size and Forecast (2017-2028)
8.3.5 India Tuberculosis Testing and Diagnostics Market Size and Forecast (2017-2028)
8.3.6 Southeast Asia Tuberculosis Testing and Diagnostics Market Size and Forecast (2017-2028)
8.3.7 Australia Tuberculosis Testing and Diagnostics Market Size and Forecast (2017-2028)
9.1 South America Tuberculosis Testing and Diagnostics Revenue by Type (2017-2028)
9.2 South America Tuberculosis Testing and Diagnostics Revenue by Application (2017-2028)
9.3 South America Tuberculosis Testing and Diagnostics Market Size by Country
9.3.1 South America Tuberculosis Testing and Diagnostics Revenue by Country (2017-2028)
9.3.2 Brazil Tuberculosis Testing and Diagnostics Market Size and Forecast (2017-2028)
9.3.3 Argentina Tuberculosis Testing and Diagnostics Market Size and Forecast (2017-2028)
10.1 Middle East & Africa Tuberculosis Testing and Diagnostics Revenue by Type (2017-2028)
10.2 Middle East & Africa Tuberculosis Testing and Diagnostics Revenue by Application (2017-2028)
10.3 Middle East & Africa Tuberculosis Testing and Diagnostics Market Size by Country
10.3.1 Middle East & Africa Tuberculosis Testing and Diagnostics Revenue by Country (2017-2028)
10.3.2 Turkey Tuberculosis Testing and Diagnostics Market Size and Forecast (2017-2028)
10.3.3 Saudi Arabia Tuberculosis Testing and Diagnostics Market Size and Forecast (2017-2028)
10.3.4 UAE Tuberculosis Testing and Diagnostics Market Size and Forecast (2017-2028)
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
Table of Figures
List of Tables
Table 1. Global Tuberculosis Testing and Diagnostics Revenue by Type, (USD Million), 2017 VS 2021 VS 2028
Table 2. Global Tuberculosis Testing and Diagnostics Revenue by Application, (USD Million), 2017 VS 2021 VS 2028
Table 3. Global Market Tuberculosis Testing and Diagnostics Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)
Table 4. Global Tuberculosis Testing and Diagnostics Revenue (USD Million) by Region (2017-2022)
Table 5. Global Tuberculosis Testing and Diagnostics Revenue Market Share by Region (2023-2028)
Table 6. Roche Corporate Information, Head Office, and Major Competitors
Table 7. Roche Major Business
Table 8. Roche Tuberculosis Testing and Diagnostics Product and Solutions
Table 9. Roche Tuberculosis Testing and Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 10. Thermo Fischer Scientific Corporate Information, Head Office, and Major Competitors
Table 11. Thermo Fischer Scientific Major Business
Table 12. Thermo Fischer Scientific Tuberculosis Testing and Diagnostics Product and Solutions
Table 13. Thermo Fischer Scientific Tuberculosis Testing and Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 14. Becton Dickinson Corporate Information, Head Office, and Major Competitors
Table 15. Becton Dickinson Major Business
Table 16. Becton Dickinson Tuberculosis Testing and Diagnostics Product and Solutions
Table 17. Becton Dickinson Tuberculosis Testing and Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 18. Abbott Corporate Information, Head Office, and Major Competitors
Table 19. Abbott Major Business
Table 20. Abbott Tuberculosis Testing and Diagnostics Product and Solutions
Table 21. Abbott Tuberculosis Testing and Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 22. Hologic Corporate Information, Head Office, and Major Competitors
Table 23. Hologic Major Business
Table 24. Hologic Tuberculosis Testing and Diagnostics Product and Solutions
Table 25. Hologic Tuberculosis Testing and Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 26. Qiagen Corporate Information, Head Office, and Major Competitors
Table 27. Qiagen Major Business
Table 28. Qiagen Tuberculosis Testing and Diagnostics Product and Solutions
Table 29. Qiagen Tuberculosis Testing and Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 30. Sanofi Corporate Information, Head Office, and Major Competitors
Table 31. Sanofi Major Business
Table 32. Sanofi Tuberculosis Testing and Diagnostics Product and Solutions
Table 33. Sanofi Tuberculosis Testing and Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 34. Oxford Immunotec Corporate Information, Head Office, and Major Competitors
Table 35. Oxford Immunotec Major Business
Table 36. Oxford Immunotec Tuberculosis Testing and Diagnostics Product and Solutions
Table 37. Oxford Immunotec Tuberculosis Testing and Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 38. BioMerieux Corporate Information, Head Office, and Major Competitors
Table 39. BioMerieux Major Business
Table 40. BioMerieux Tuberculosis Testing and Diagnostics Product and Solutions
Table 41. BioMerieux Tuberculosis Testing and Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 42. Par Sterile Corporate Information, Head Office, and Major Competitors
Table 43. Par Sterile Major Business
Table 44. Par Sterile Tuberculosis Testing and Diagnostics Product and Solutions
Table 45. Par Sterile Tuberculosis Testing and Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 46. Bio-Rad Laboratories Corporate Information, Head Office, and Major Competitors
Table 47. Bio-Rad Laboratories Major Business
Table 48. Bio-Rad Laboratories Tuberculosis Testing and Diagnostics Product and Solutions
Table 49. Bio-Rad Laboratories Tuberculosis Testing and Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 50. Akonni Biosystems Corporate Information, Head Office, and Major Competitors
Table 51. Akonni Biosystems Major Business
Table 52. Akonni Biosystems Tuberculosis Testing and Diagnostics Product and Solutions
Table 53. Akonni Biosystems Tuberculosis Testing and Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 54. Cepheid Corporate Information, Head Office, and Major Competitors
Table 55. Cepheid Major Business
Table 56. Cepheid Tuberculosis Testing and Diagnostics Product and Solutions
Table 57. Cepheid Tuberculosis Testing and Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 58. Siemens Healthineer Corporate Information, Head Office, and Major Competitors
Table 59. Siemens Healthineer Major Business
Table 60. Siemens Healthineer Tuberculosis Testing and Diagnostics Product and Solutions
Table 61. Siemens Healthineer Tuberculosis Testing and Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 62. Hain Lifescience Corporate Information, Head Office, and Major Competitors
Table 63. Hain Lifescience Major Business
Table 64. Hain Lifescience Tuberculosis Testing and Diagnostics Product and Solutions
Table 65. Hain Lifescience Tuberculosis Testing and Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 66. Epistem Corporate Information, Head Office, and Major Competitors
Table 67. Epistem Major Business
Table 68. Epistem Tuberculosis Testing and Diagnostics Product and Solutions
Table 69. Epistem Tuberculosis Testing and Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 70. Creative Diagnostics Corporate Information, Head Office, and Major Competitors
Table 71. Creative Diagnostics Major Business
Table 72. Creative Diagnostics Tuberculosis Testing and Diagnostics Product and Solutions
Table 73. Creative Diagnostics Tuberculosis Testing and Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 74. Global Tuberculosis Testing and Diagnostics Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)
Table 75. Global Tuberculosis Testing and Diagnostics Revenue Share by Players (2019, 2020, 2021, and 2022)
Table 76. Breakdown of Tuberculosis Testing and Diagnostics by Company Type (Tier 1, Tier 2 and Tier 3)
Table 77. Tuberculosis Testing and Diagnostics Players Head Office, Products and Services Provided
Table 78. Tuberculosis Testing and Diagnostics Mergers & Acquisitions in the Past Five Years
Table 79. Tuberculosis Testing and Diagnostics New Entrants and Expansion Plans
Table 80. Global Tuberculosis Testing and Diagnostics Revenue (USD Million) by Type (2017-2022)
Table 81. Global Tuberculosis Testing and Diagnostics Revenue Share by Type (2017-2022)
Table 82. Global Tuberculosis Testing and Diagnostics Revenue Forecast by Type (2023-2028)
Table 83. Global Tuberculosis Testing and Diagnostics Revenue by Application (2017-2022)
Table 84. Global Tuberculosis Testing and Diagnostics Revenue Forecast by Application (2023-2028)
Table 85. North America Tuberculosis Testing and Diagnostics Revenue by Type (2017-2022) & (USD Million)
Table 86. North America Tuberculosis Testing and Diagnostics Revenue by Type (2023-2028) & (USD Million)
Table 87. North America Tuberculosis Testing and Diagnostics Revenue by Application (2017-2022) & (USD Million)
Table 88. North America Tuberculosis Testing and Diagnostics Revenue by Application (2023-2028) & (USD Million)
Table 89. North America Tuberculosis Testing and Diagnostics Revenue by Country (2017-2022) & (USD Million)
Table 90. North America Tuberculosis Testing and Diagnostics Revenue by Country (2023-2028) & (USD Million)
Table 91. Europe Tuberculosis Testing and Diagnostics Revenue by Type (2017-2022) & (USD Million)
Table 92. Europe Tuberculosis Testing and Diagnostics Revenue by Type (2023-2028) & (USD Million)
Table 93. Europe Tuberculosis Testing and Diagnostics Revenue by Application (2017-2022) & (USD Million)
Table 94. Europe Tuberculosis Testing and Diagnostics Revenue by Application (2023-2028) & (USD Million)
Table 95. Europe Tuberculosis Testing and Diagnostics Revenue by Country (2017-2022) & (USD Million)
Table 96. Europe Tuberculosis Testing and Diagnostics Revenue by Country (2023-2028) & (USD Million)
Table 97. Asia-Pacific Tuberculosis Testing and Diagnostics Revenue by Type (2017-2022) & (USD Million)
Table 98. Asia-Pacific Tuberculosis Testing and Diagnostics Revenue by Type (2023-2028) & (USD Million)
Table 99. Asia-Pacific Tuberculosis Testing and Diagnostics Revenue by Application (2017-2022) & (USD Million)
Table 100. Asia-Pacific Tuberculosis Testing and Diagnostics Revenue by Application (2023-2028) & (USD Million)
Table 101. Asia-Pacific Tuberculosis Testing and Diagnostics Revenue by Region (2017-2022) & (USD Million)
Table 102. Asia-Pacific Tuberculosis Testing and Diagnostics Revenue by Region (2023-2028) & (USD Million)
Table 103. South America Tuberculosis Testing and Diagnostics Revenue by Type (2017-2022) & (USD Million)
Table 104. South America Tuberculosis Testing and Diagnostics Revenue by Type (2023-2028) & (USD Million)
Table 105. South America Tuberculosis Testing and Diagnostics Revenue by Application (2017-2022) & (USD Million)
Table 106. South America Tuberculosis Testing and Diagnostics Revenue by Application (2023-2028) & (USD Million)
Table 107. South America Tuberculosis Testing and Diagnostics Revenue by Country (2017-2022) & (USD Million)
Table 108. South America Tuberculosis Testing and Diagnostics Revenue by Country (2023-2028) & (USD Million)
Table 109. Middle East & Africa Tuberculosis Testing and Diagnostics Revenue by Type (2017-2022) & (USD Million)
Table 110. Middle East & Africa Tuberculosis Testing and Diagnostics Revenue by Type (2023-2028) & (USD Million)
Table 111. Middle East & Africa Tuberculosis Testing and Diagnostics Revenue by Application (2017-2022) & (USD Million)
Table 112. Middle East & Africa Tuberculosis Testing and Diagnostics Revenue by Application (2023-2028) & (USD Million)
Table 113. Middle East & Africa Tuberculosis Testing and Diagnostics Revenue by Country (2017-2022) & (USD Million)
Table 114. Middle East & Africa Tuberculosis Testing and Diagnostics Revenue by Country (2023-2028) & (USD Million)
List of Figures
Figure 1. Tuberculosis Testing and Diagnostics Picture
Figure 2. Global Tuberculosis Testing and Diagnostics Revenue Market Share by Type in 2021
Figure 3. Smear Microscopy
Figure 4. Nucleic Acid Testing
Figure 5. Radiography
Figure 6. Tuberculin Skin Test (TST)
Figure 7. Interferon Gamma Released Assay (IGRA)
Figure 8. Others
Figure 9. Tuberculosis Testing and Diagnostics Revenue Market Share by Application in 2021
Figure 10. Hospitals and Clinics Picture
Figure 11. Diagnostic Laboratories Picture
Figure 12. Others Picture
Figure 13. Global Tuberculosis Testing and Diagnostics Market Size, (USD Million): 2017 VS 2021 VS 2028
Figure 14. Global Tuberculosis Testing and Diagnostics Revenue and Forecast (2017-2028) & (USD Million)
Figure 15. Global Tuberculosis Testing and Diagnostics Revenue Market Share by Region (2017-2028)
Figure 16. Global Tuberculosis Testing and Diagnostics Revenue Market Share by Region in 2021
Figure 17. North America Tuberculosis Testing and Diagnostics Revenue (USD Million) and Growth Rate (2017-2028)
Figure 18. Europe Tuberculosis Testing and Diagnostics Revenue (USD Million) and Growth Rate (2017-2028)
Figure 19. Asia-Pacific Tuberculosis Testing and Diagnostics Revenue (USD Million) and Growth Rate (2017-2028)
Figure 20. South America Tuberculosis Testing and Diagnostics Revenue (USD Million) and Growth Rate (2017-2028)
Figure 21. Middle East and Africa Tuberculosis Testing and Diagnostics Revenue (USD Million) and Growth Rate (2017-2028)
Figure 22. Tuberculosis Testing and Diagnostics Market Drivers
Figure 23. Tuberculosis Testing and Diagnostics Market Restraints
Figure 24. Tuberculosis Testing and Diagnostics Market Trends
Figure 25. Roche Recent Developments and Future Plans
Figure 26. Thermo Fischer Scientific Recent Developments and Future Plans
Figure 27. Becton Dickinson Recent Developments and Future Plans
Figure 28. Abbott Recent Developments and Future Plans
Figure 29. Hologic Recent Developments and Future Plans
Figure 30. Qiagen Recent Developments and Future Plans
Figure 31. Sanofi Recent Developments and Future Plans
Figure 32. Oxford Immunotec Recent Developments and Future Plans
Figure 33. BioMerieux Recent Developments and Future Plans
Figure 34. Par Sterile Recent Developments and Future Plans
Figure 35. Bio-Rad Laboratories Recent Developments and Future Plans
Figure 36. Akonni Biosystems Recent Developments and Future Plans
Figure 37. Cepheid Recent Developments and Future Plans
Figure 38. Siemens Healthineer Recent Developments and Future Plans
Figure 39. Hain Lifescience Recent Developments and Future Plans
Figure 40. Epistem Recent Developments and Future Plans
Figure 41. Creative Diagnostics Recent Developments and Future Plans
Figure 42. Global Tuberculosis Testing and Diagnostics Revenue Share by Players in 2021
Figure 43. Tuberculosis Testing and Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021
Figure 44. Global Top 3 Players Tuberculosis Testing and Diagnostics Revenue Market Share in 2021
Figure 45. Global Top 10 Players Tuberculosis Testing and Diagnostics Revenue Market Share in 2021
Figure 46. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)
Figure 47. Global Tuberculosis Testing and Diagnostics Revenue Share by Type in 2021
Figure 48. Global Tuberculosis Testing and Diagnostics Market Share Forecast by Type (2023-2028)
Figure 49. Global Tuberculosis Testing and Diagnostics Revenue Share by Application in 2021
Figure 50. Global Tuberculosis Testing and Diagnostics Market Share Forecast by Application (2023-2028)
Figure 51. North America Tuberculosis Testing and Diagnostics Sales Market Share by Type (2017-2028)
Figure 52. North America Tuberculosis Testing and Diagnostics Sales Market Share by Application (2017-2028)
Figure 53. North America Tuberculosis Testing and Diagnostics Revenue Market Share by Country (2017-2028)
Figure 54. United States Tuberculosis Testing and Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 55. Canada Tuberculosis Testing and Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 56. Mexico Tuberculosis Testing and Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Europe Tuberculosis Testing and Diagnostics Sales Market Share by Type (2017-2028)
Figure 58. Europe Tuberculosis Testing and Diagnostics Sales Market Share by Application (2017-2028)
Figure 59. Europe Tuberculosis Testing and Diagnostics Revenue Market Share by Country (2017-2028)
Figure 60. Germany Tuberculosis Testing and Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. France Tuberculosis Testing and Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. United Kingdom Tuberculosis Testing and Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. Russia Tuberculosis Testing and Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. Italy Tuberculosis Testing and Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 65. Asia-Pacific Tuberculosis Testing and Diagnostics Sales Market Share by Type (2017-2028)
Figure 66. Asia-Pacific Tuberculosis Testing and Diagnostics Sales Market Share by Application (2017-2028)
Figure 67. Asia-Pacific Tuberculosis Testing and Diagnostics Revenue Market Share by Region (2017-2028)
Figure 68. China Tuberculosis Testing and Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 69. Japan Tuberculosis Testing and Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 70. South Korea Tuberculosis Testing and Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 71. India Tuberculosis Testing and Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 72. Southeast Asia Tuberculosis Testing and Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Australia Tuberculosis Testing and Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. South America Tuberculosis Testing and Diagnostics Sales Market Share by Type (2017-2028)
Figure 75. South America Tuberculosis Testing and Diagnostics Sales Market Share by Application (2017-2028)
Figure 76. South America Tuberculosis Testing and Diagnostics Revenue Market Share by Country (2017-2028)
Figure 77. Brazil Tuberculosis Testing and Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 78. Argentina Tuberculosis Testing and Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 79. Middle East and Africa Tuberculosis Testing and Diagnostics Sales Market Share by Type (2017-2028)
Figure 80. Middle East and Africa Tuberculosis Testing and Diagnostics Sales Market Share by Application (2017-2028)
Figure 81. Middle East and Africa Tuberculosis Testing and Diagnostics Revenue Market Share by Country (2017-2028)
Figure 82. Turkey Tuberculosis Testing and Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 83. Saudi Arabia Tuberculosis Testing and Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 84. UAE Tuberculosis Testing and Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 85. Methodology
Figure 86. Research Process and Data Source
Research Methodology
Client Requirements
Review and analyze client requirements
Discussion of all the project requirements and queries
Flexibility Check
Project Feasibility Analysis
Finalizing tentative research programme
Structuring project proposal with scope, timeline, and costs
Analyzing Market Dynamics
Determination of key drivers, restraints, challenge, and opportunity
Identifies market needs and trends
Market Size Estimation & Forecast
Estimation of historical data based on secondary and primary data
Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)
Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies
Consideration of geography, region-specific product/service demand for region segments
Consideration of product utilization rates, product demand outlook for segments by application or end-user.
Data Source
Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports,
paid database, press releases, blogs, newsletters,and GIR repositories.
Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts
to verify insights.
Validation
and
triangulation of
secondary and primary source.
Collection of data
Cumulating and collating the essential qualitative and quantitative data
Generation of report in client requested format by research analysts
Reviews by expert analysts
Final quality check
Clarifying queries
Receiving feedback
Ensuring satisfaction
01 Identification of data
This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
-
02 Evaluation of Market Dynamic
This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
-
03 Collection of Data
This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
-
04 Collaboration of Data
This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis
This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.
Companies Mentioned
Roche Thermo Fischer Scientific Becton Dickinson Abbott Hologic Qiagen Sanofi Oxford Immunotec BioMerieux Par Sterile Bio-Rad Laboratories Akonni Biosystems Cepheid Siemens Healthineer Hain Lifescience Epistem Creative Diagnostics
01 Feb 2021
Medical Care
Purchase Options
Add To Cart
Buy Now
Popular Product Keywords
- We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.Speak to our analyst >>
Our Clients
What We Can Provide?
With better results and higher quality products,Our professional reports can achieve four things:
Insight into the industry market information
Analyze market development needs
Prospects for future development
Develop industry investment strategy
- Digging deeper into global industry information and providing market strategies.Contact Us >>
